{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T10:41:13Z","timestamp":1776940873307,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45158-0","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:16:56Z","timestamp":1774984616000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analyzing fourteen deleterious nsSNPs of CFTR as promising genetic markers for cancer prognosis"],"prefix":"10.1038","volume":"16","author":[{"given":"Seyyedha","family":"Abbas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Shabbir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmin","family":"Badshah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fizzah","family":"Abid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khushbukhat","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amna","family":"Hafeez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naeem Mahmood","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janeen H.","family":"Trembley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tayyaba","family":"Afsar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Altaf","family":"khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadia","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhail","family":"Razak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"issue":"3","key":"45158_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/85776","volume":"27","author":"L Kruglyak","year":"2001","unstructured":"Kruglyak, L. & Nickerson, D. A. Variation is the spice of life. Nat. Genet. 27(3), 234\u2013236 (2001).","journal-title":"Nat. Genet."},{"issue":"4","key":"45158_CR2","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/genes13040672","volume":"13","author":"MZ Ali","year":"2022","unstructured":"Ali, M. Z. et al. In silico analysis identified putative pathogenic missense nsSNPs in human SLITRK1 gene. Genes 13 (4), 672 (2022).","journal-title":"Genes"},{"issue":"2","key":"45158_CR3","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1006\/jmbi.2001.4510","volume":"307","author":"D Chasman","year":"2001","unstructured":"Chasman, D. & Adams, R. M. Predicting the functional consequences of non-synonymous single nucleotide polymorphisms: Structure-based assessment of amino acid variation. J. Mol. Biol. 307(2), 683\u2013706 (2001).","journal-title":"J. Mol. Biol."},{"key":"45158_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.sbi.2015.01.003","volume":"32","author":"TG Kucukkal","year":"2015","unstructured":"Kucukkal, T. G., Petukh, M., Li, L. & Alexov, E. Structural and physico-chemical effects of disease and non-disease nsSNPs on proteins. Curr. Opin. Struct. Biol. 32, 18\u201324 (2015).","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"1","key":"45158_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1086\/302460","volume":"65","author":"R Thomas","year":"1999","unstructured":"Thomas, R. et al. Identification of mutations in the repeated part of the autosomal dominant polycystic kidney disease type 1 gene, PKD1, by long-range PCR. Am. J. Hum. Genet. 65(1), 39\u201349 (1999).","journal-title":"Am. J. Hum. Genet."},{"issue":"21","key":"45158_CR6","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1016\/j.jmb.2013.07.012","volume":"425","author":"CM Yates","year":"2013","unstructured":"Yates, C. M. & Sternberg, M. J. The effects of non-synonymous single nucleotide polymorphisms (nsSNPs) on protein\u2013protein interactions. J. Mol. Biol. 425(21), 3949\u20133963 (2013).","journal-title":"J. Mol. Biol."},{"issue":"1","key":"45158_CR7","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a009498","volume":"3","author":"T-C Hwang","year":"2013","unstructured":"Hwang, T.-C. & Kirk, K. L. The CFTR ion channel: Gating, regulation, and anion permeation. Cold. Spring. Harb. Perspect. Med. 3(1), a009498 (2013).","journal-title":"Cold. Spring. Harb. Perspect. Med."},{"issue":"4","key":"45158_CR8","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1042\/BST0370863","volume":"37","author":"PJ Buchanan","year":"2009","unstructured":"Buchanan, P. J., Ernst, R. K., Elborn, J. S. & Schock, B. Role of CFTR, Pseudomonas aeruginosa and Toll-like receptors in cystic fibrosis lung inflammation. Biochem. Soc. Trans. 37(4), 863\u2013867 (2009).","journal-title":"Biochem. Soc. Trans."},{"issue":"10","key":"45158_CR9","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1113\/jphysiol.2008.164970","volume":"587","author":"HC Chan","year":"2009","unstructured":"Chan, H. C. et al. The cystic fibrosis transmembrane conductance regulator in reproductive health and disease. J. Physiol. 587(10), 2187\u20132195 (2009).","journal-title":"J. Physiol."},{"issue":"8","key":"45158_CR10","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/j.1440-1843.2011.01994.x","volume":"16","author":"JW Son","year":"2011","unstructured":"Son, J. W. et al. Promoter hypermethylation of the CFTR gene and clinical\/pathological features associated with non-small cell lung cancer. Respirology 16(8), 1203\u20131209 (2011).","journal-title":"Respirology"},{"issue":"5","key":"45158_CR11","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.3892\/ijo.2015.2921","volume":"46","author":"J Li","year":"2015","unstructured":"Li, J. et al. The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer. Int. J. Oncol. 46(5), 2107\u20132115 (2015).","journal-title":"Int. J. Oncol."},{"issue":"2","key":"45158_CR12","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/cbin.11260","volume":"44","author":"K Liu","year":"2020","unstructured":"Liu, K. et al. Promoter hypermethylation of the CFTR gene as a novel diagnostic and prognostic marker of breast cancer. Cell Biol. Int. 44(2), 603\u2013609 (2020).","journal-title":"Cell Biol. Int."},{"issue":"1","key":"45158_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/sj.onc.1209764","volume":"26","author":"AP Singh","year":"2007","unstructured":"Singh, A. P. et al. MUC4 expression is regulated by cystic fibrosis transmembrane conductance regulator in pancreatic adenocarcinoma cells via transcriptional and post-translational mechanisms. Oncogene 26 (1), 30\u201341 (2007).","journal-title":"Oncogene"},{"issue":"32","key":"45158_CR14","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1038\/onc.2015.483","volume":"35","author":"B Than","year":"2016","unstructured":"Than, B. et al. CFTR is a tumor suppressor gene in murine and human intestinal cancer. Oncogene 35 (32), 4191\u20134199 (2016).","journal-title":"Oncogene"},{"issue":"18","key":"45158_CR15","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1038\/onc.2012.251","volume":"32","author":"C Xie","year":"2013","unstructured":"Xie, C. et al. CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer. Oncogene 32 (18), 2282\u20132291 (2013).","journal-title":"Oncogene"},{"key":"45158_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2014.00339","volume":"4","author":"KE Royse","year":"2014","unstructured":"Royse, K. E. et al. Differential gene expression landscape of co-existing cervical pre-cancer lesions using RNA-seq. Front. Oncol. 4, 339 (2014).","journal-title":"Front. Oncol."},{"issue":"4","key":"45158_CR17","doi-asserted-by":"publisher","first-page":"718","DOI":"10.4143\/crt.2014.064","volume":"47","author":"Y-S Suh","year":"2015","unstructured":"Suh, Y.-S. et al. Overexpression of plasminogen activator inhibitor-1 in advanced gastric cancer with aggressive lymph node metastasis. Cancer Res. Treat. 47(4), 718\u2013726 (2015).","journal-title":"Cancer Res. Treat."},{"issue":"5","key":"45158_CR18","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.3892\/or.2015.3829","volume":"33","author":"J Xu","year":"2015","unstructured":"Xu, J. et al. High level of CFTR expression is associated with tumor aggression and knockdown of CFTR suppresses proliferation of ovarian cancer in vitro and in vivo. J Oncology reports 33(5), 2227\u20132234 (2015).","journal-title":"J Oncology reports"},{"issue":"3","key":"45158_CR19","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1073\/pnas.97.3.1172","volume":"97","author":"RE Ellsworth","year":"2000","unstructured":"Ellsworth, R. E. et al. Comparative genomic sequence analysis of the human and mouse cystic fibrosis transmembrane conductance regulator genes. Proc. Natl. Acad. Sci. U. S. A. 97(3), 1172\u20131177 (2000).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4922","key":"45158_CR20","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1126\/science.2570460","volume":"245","author":"B-s Kerem","year":"1989","unstructured":"Kerem, B.-s et al. Identification of the cystic fibrosis gene: Genetic analysis. Science 245(4922), 1073\u20131080 (1989).","journal-title":"Science"},{"issue":"1","key":"45158_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/nargab\/lqab122","volume":"4","author":"D Wang","year":"2022","unstructured":"Wang, D., Li, J., Wang, Y. & Wang, E. A comparison on predicting functional impact of genomic variants. NAR Genom Bioinform. 4(1), lqab122 (2022).","journal-title":"NAR Genom Bioinform."},{"issue":"1","key":"45158_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-022-00437-6","volume":"10","author":"F Abid","year":"2022","unstructured":"Abid, F. et al. Analyzing PKC Gamma (+\u200919,506 A\/G) polymorphism as a promising genetic marker for HCV-induced hepatocellular carcinoma. Biomark Res. 10(1), 87 (2022).","journal-title":"Biomark Res."},{"issue":"1","key":"45158_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12935-023-02965-z","volume":"23","author":"F Abid","year":"2023","unstructured":"Abid, F. et al. Non-synonymous SNPs variants of PRKCG and its association with oncogenes predispose to hepatocellular carcinoma. Cancer Cell Int. 23 (1), 123 (2023).","journal-title":"Cancer Cell Int."},{"key":"45158_CR24","doi-asserted-by":"crossref","unstructured":"Zimbru, C. G. et al. Performance Evaluation of in Silico Predictors for the Classification of ClinVar Variants. In: 2019 E-Health and Bioengineering Conference (EHB): 2019: IEEE; : 1\u20134. (2019).","DOI":"10.1109\/EHB47216.2019.8969963"},{"issue":"1","key":"45158_CR25","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13568-024-01742-z","volume":"14","author":"A Akram","year":"2024","unstructured":"Akram, A. et al. Silibinins and curcumin as promising ligands against mutant cystic fibrosis transmembrane regulator protein. AMB Express. 14 (1), 84 (2024).","journal-title":"AMB Express"},{"issue":"20","key":"45158_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167208","volume":"433","author":"KM Ruff","year":"2021","unstructured":"Ruff, K. M. & Pappu, R. V. AlphaFold and implications for intrinsically disordered proteins. J. Mol. Biol. 433(20), 167208 (2021).","journal-title":"J. Mol. Biol."},{"issue":"D1","key":"45158_CR27","doi-asserted-by":"publisher","first-page":"D418","DOI":"10.1093\/nar\/gkac993","volume":"51","author":"T Paysan-Lafosse","year":"2023","unstructured":"Paysan-Lafosse, T. et al. InterPro in 2022. Nucleic acids research 51(D1), D418\u2013D427 (2023).","journal-title":"Nucleic acids research"},{"issue":"2","key":"45158_CR28","doi-asserted-by":"crossref","DOI":"10.1002\/wics.1425","volume":"7","author":"S Yuan","year":"2017","unstructured":"Yuan, S., Chan, H. S. & Hu, Z. Using PyMOL as a platform for computational drug design. Wiley Interdisciplinary Reviews: Computational Molecular Science 7(2), e1298 (2017).","journal-title":"Wiley Interdisciplinary Reviews: Computational Molecular Science"},{"issue":"2","key":"45158_CR29","doi-asserted-by":"publisher","first-page":"e700","DOI":"10.20883\/medical.e700","volume":"91","author":"N Sawicka-Gutaj","year":"2022","unstructured":"Sawicka-Gutaj, N., Gruszczy\u0144ski, D., Guzik, P., Mostowska, A. & Walkowiak, J. Publication ethics of human studies in the light of the Declaration of Helsinki\u2013A mini-review. Journal of Medical Science 91(2), e700\u2013e700 (2022).","journal-title":"Journal of Medical Science"},{"issue":"3","key":"45158_CR30","first-page":"120","volume":"62","author":"M Ghaheri","year":"2016","unstructured":"Ghaheri, M. et al. A comparative evaluation of four DNA extraction protocols from whole blood sample. Cellular and Molecular Biology 62(3), 120\u2013124 (2016).","journal-title":"Cellular and Molecular Biology"},{"key":"45158_CR31","doi-asserted-by":"crossref","unstructured":"Mukherjee, A. & Chattopadhyay, T. Tetra-primer amplification refractory mutation system (T-ARMS). In Plant Genotyping: Methods and Protocols 315\u2013325 (Springer, 2023).","DOI":"10.1007\/978-1-0716-3024-2_22"},{"key":"45158_CR32","doi-asserted-by":"crossref","unstructured":"Thornton, B. & Basu, C. Rapid and simple method of qPCR primer design. In PCR primer design 173\u2013179 (Springer, 2015).","DOI":"10.1007\/978-1-4939-2365-6_13"},{"key":"45158_CR33","unstructured":"Joseph, M. Chi-square test, relative risk, odds ratio, correlation. In: APHA 2024 Annual Meeting and Expo: 2024: APHA; (2024)."},{"issue":"8","key":"45158_CR34","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/s41416-018-0117-7","volume":"119","author":"E Theodoratou","year":"2018","unstructured":"Theodoratou, E. et al. Genome-wide scan of the effect of common nsSNPs on colorectal cancer survival outcome. British Journal of Cancer 119(8), 988\u2013993 (2018).","journal-title":"British Journal of Cancer"},{"issue":"1","key":"45158_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-95618-y","volume":"11","author":"NA Khoruddin","year":"2021","unstructured":"Khoruddin, N. A., Noorizhab, M. N., Teh, L. K., Mohd Yusof, F. Z. & Salleh, M. Z. Pathogenic nsSNPs that increase the risks of cancers among the Orang Asli and Malays. Scientific Reports 11(1), 16158 (2021).","journal-title":"Scientific Reports"},{"issue":"4","key":"45158_CR36","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/brain\/awac431","volume":"146","author":"V Vivekanandam","year":"2023","unstructured":"Vivekanandam, V. et al. In silico versus functional characterization of genetic variants: Lessons from muscle channelopathies. Brain 146(4), 1316\u20131321 (2023).","journal-title":"Brain"},{"issue":"2","key":"45158_CR37","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jsb.2016.07.011","volume":"197","author":"DN Mastronarde","year":"2017","unstructured":"Mastronarde, D. N. & Held, S. R. Automated tilt series alignment and tomographic reconstruction in IMOD. J. Struct. Biol. 197(2), 102\u2013113 (2017).","journal-title":"J. Struct. Biol."},{"issue":"5","key":"45158_CR38","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1086\/429864","volume":"76","author":"JE Wigginton","year":"2005","unstructured":"Wigginton, J. E., Cutler, D. J. & Abecasis, G. A note on exact tests of Hardy-Weinberg equilibrium. The American Journal of Human Genetics 76(5), 887\u2013893 (2005).","journal-title":"The American Journal of Human Genetics"},{"issue":"9","key":"45158_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9091116","volume":"9","author":"Y-T Kao","year":"2021","unstructured":"Kao, Y.-T. et al. Novel coagulation factor VIII gene therapy in a mouse model of Hemophilia A by lipid-coated Fe3O4 nanoparticles. Biomedicines 9(9), 1116 (2021).","journal-title":"Biomedicines"},{"issue":"8","key":"45158_CR40","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41419-019-1809-5","volume":"10","author":"Y-B Hu","year":"2019","unstructured":"Hu, Y-B. et al. miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson\u2019s disease. Cell Death Dis. 10 (8), 589 (2019).","journal-title":"Cell Death Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45158-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45158-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45158-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T09:49:29Z","timestamp":1776937769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45158-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45158"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45158-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the ethical committee of Polyclinic Hospital, Islamabad and ASAB, NUST. Informed consent was obtained from all subjects and\/or their legal guardian(s). All methods were performed in accordance with the relevant guidelines and regulations. The study was conducted in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"13261"}}